Conferences - Results from #9540

Viewing 9541-9560 of 11531 articles

ASCO GU 2017: In Advanced Kidney Cancer, Antibiotic Use Lowers Efficacy of Immunotherapy

Radium-223 with concomitant bone-targeting agents in metastatic castration-resistant prostate cancer (CRPC) patients treated in an international early access program (EAP)

Changes in alkaline phosphatase (ALP) dynamics and overall survival (OS) in metastatic castration-resistant prostate cancer (mCRPC) patients treated with radium-223.

Role of FSH in the musculoskeletal side effects associated with androgen deprivation therapy (ADT) for prostate cancer

2017 Genitourinary Cancers Symposium Press Program to Feature Research Advances in Prostate, Urothelial, Kidney Cancers

SUO 2016: Immunotherapy for Prostate Cancer: What is the Way Forward? - Session Highlights

SUO 2016: State-of-the-Art Lecture: Advances in Management in of Metastatic RCC - Session Highlights

SUO 2016: SLCO2B1: Biology & Therapeutic Implications - Session Highlights

SUO 2016: Oral Abstract – Lymph node yield as a predictor of overall survival following regional lymphadenectomy for penile cancer - Session Highlights

SUO 2016: Potential Therapeutic approaches to neuroendocrine prostate cancer - Session Highlights

SUO 2016: EAU Lecture: ProtecT trial - Session Highlights

SUO 2016: Targeting DNA repair pathways in prostate cancer - Session Highlights

SUO 2016: Mechanisms of Resistance to AR: AR Variants and GR - Session Highlights

SUO 2016: Novel predictive biomarkers for benefit of chemotherapy focusing on ERCC2 and other platinum sensitivity biomarkers - Session Highlights

SUO 2016: Novel predictive biomarkers for benefit of immune checkpoint blockade - Session Highlights

SUO 2016: Prevalence and prognostic significance of circulating tumor cells in clinically localized prostate cancer - Session Highlights

SUO 2016: Prospective multicenter comparison of open and robotic radical prostatectomy: the Prost-QA/RP2 consortium - Session Highlights

SUO 2016: Definite Treatment of Bladder Cancer in Octogenarians: Balancing Increased Perioperative Mortality with Superior Overall Survival - Poster Session Highlights

SUO 2016: Absence of Tumor on Repeat TURBT does not Predict Final Pathologic T0 Stage in Muscle Invasive Bladder Cancer Treated with Radical Cystectomy - Poster Session Highlights

SUO 2016: Panel on Surgical Management for Advanced Kidney Cancer: Controversies in Case Management - Session Highlights

473
474
475
476
477
478
479
480
481
482